Thrombolome and Its Emerging Role in Chronic Kidney Diseases
Patients with chronic kidney disease (CKD) are at an increased risk of thromboembolic complications, including myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism. These complications lead to increased mortality. Evidence points to the key role of CKD-associated dysbiosis and...
Main Authors: | Justyna Fryc, Beata Naumnik |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/13/3/223 |
Similar Items
-
Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production
by: Yingyi Wang, et al.
Published: (2020-11-01) -
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
by: Olivier Deltombe, et al.
Published: (2015-09-01) -
Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
by: Joosep Paats, et al.
Published: (2020-02-01) -
Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
by: Eya Hamza, et al.
Published: (2020-09-01) -
Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients
by: Stanislas Bataille, et al.
Published: (2017-07-01)